enGene Holdings Inc. (ENGN)
2025-07-31 | ||||
---|---|---|---|---|
Unrealized loss (gain) on available-for-sale investments | -240 | |||
Provision for (recovery of) income taxes | 239 | |||
Research and development | 22,575 | |||
General and administrative | 7,372 | |||
Total operating expenses | 29,947 | |||
Loss from operations | -29,947 | |||
Other expenses (income), net | -280 | |||
Interest income | 2,233 | |||
Interest expense | 758 | |||
Total other income, net | 1,195 | |||
Net loss before income taxes | -28,752 | |||
Net loss | -28,991 | |||
Total comprehensive loss | -29,231 | |||
Earnings per share, basic, total | 0.57 | |||
Earnings per share, diluted, total | 0.57 | |||
Weighted-average number of common shares used in net loss per share, basic | 51,097,711 | |||
Weighted-average number of common shares used in net loss per share, diluted | 51,097,711 |